When was Genewiz founded?

Genewiz was founded in 1999 and raised its 1st funding round 17 years after it was founded.

Where is Genewiz located?

Genewiz is headquartered in South Plainfield, United States. It is registered at South Plainfield, New Jersey.

Who is the current CEO of Genewiz?

Amy Liao of Genewiz. They have also founded 1 company and are an angel investors in 1 startup.

How many employees does Genewiz have?

As of Aug 31, 2026, the latest employee count at Genewiz is 8.

Is Genewiz a funded company?

Genewiz is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** PE round, raised on Jan 11, 2016.

When was the latest funding round of Genewiz?

Genewiz's latest funding was a $***** Grant (prize money) round on Jun 01, 2020, with participation from 1 investor.

Where does Genewiz rank among its competitors?

Genewiz ranks 32nd amongst 624 active competitors, of which 61 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was ONCOHOST, which secured $2.8M in May, 2025.

Who are the top competitors of Genewiz?

Genewiz's top competitors include Strand Life Sciences, BGI and Enara Bio. Among them, ONCOHOST secured the most recent funding round in May, 2025.

Genewiz - 2026 Company Profile, Team, Funding & Competitors

Q: Is Genewiz an acquired company?

Genewiz got acquired by Brooks Automation on Sep 26, 2018.

Genewiz is an acquired company based in South Plainfield (United States), founded in 1999 by Amy Liao and Steve Sun. It operates as a Provider of a wide range of genomic services for the life sciences industry. Genewiz has raised an undisclosed amount in funding. The company has 624 active competitors, including 61 funded and 66 that have exited. Its top competitors include companies like Strand Life Sciences, BGI and Enara Bio.

Company Details

Provider of a wide range of genomic services for the life sciences industry. The company's services include DNA sequencing, gene synthesis, plasmid preparation, site-directed mutagenesis, fragment analysis, SNP discovery sequencing, GLP/cGMP regulatory services, next-generation sequencing, bioinformatics, and other molecular biology and genomic services.

Website: www.genewiz.com/
Social
Registered Address: South Plainfield, New Jersey

Key Metrics

Founded Year

1999

Location

South Plainfield, United States

Stage

Acquired

Latest Funding Round

Grant (prize money), Jun 01, 2020, $*****

Investors

Orbimed & 7 more

Ranked

32^nd among 624 active competitors

Employee Count

8 as on Aug 31, 2026

Investment & Acquisitions

Beckman Coulter Genomics

Similar Companies

Strand Life Sciences & 859 more

Exit Details

Acquired by Brooks Automation (Sep 26, 2018)

View Genewiz's full profile

Genewiz is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
GENEWIZ UK LIMITED CIN: 9937828 , United Kingdom, Active	Jan 05, 2016	£10M - £50M (As on Sep 30, 2024)	33 (As on Sep 30, 2024)
GENEWIZ, LLC CIN: 300832316 , United States, Active	Dec 26, 999	-	452 (As on Dec 31, 2018)	-

Genewiz got acquired by Brooks Automation on Sep 26, 2018 at an acquisition amount of $*****.

Click here to take a look at Genewiz's acquisition in detail

Genewiz has raised funding over 2 rounds. Its first funding round was on Jan 11, 2016. Its latest funding round was a Grant (prize money) round on Jun 01, 2020 for $*****. 1 investor participated in its latest round. Genewiz has 8 institutional investors.

Here is the list of recent funding rounds of Genewiz:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 01, 2020	2862963	Grant (prize money)	5771837	2735628	9442056	2112552
Jan 11, 2016	1103409	PE	1998952	2281413	8041568	Orbimed & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Genewiz's funding rounds and investors

The founders of Genewiz are Amy Liao and Steve Sun. Amy Liao is the CEO of Genewiz.

Here are the details of Genewiz's key team members:

Amy Liao: Co-Founder & CEO of Genewiz. They are also an angel investor in 1 startup.
Contact Info: 1 email address
Steve Sun: Co-Founder of Genewiz.

View details of Genewiz's Founder profiles and Board Members

Genewiz's employee count trend

Genewiz has 8 employees as of Aug 26. Here is Genewiz's employee count trend over the years:

Uncover Genewiz's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Genewiz include Strand Life Sciences, BGI and Enara Bio. Here is the list of Top 10 competitors of Genewiz, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, WestBridge Capital & 92 others	74/100
2nd	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Sequoia Capital China, Yunfeng Capital & 15 others	64/100
3rd	Enara Bio 2016, Oxford (United Kingdom), Series B	Developer of T-cell based cancer-cell interface for therapeutics	$84.1M	SV Health Investors, M Ventures & 36 others	53/100
4th	Berry Genomics 2010, Beijing (China), Public	Provider of genetic testing products and tests	$16M	Legend Capital, TMCP & 6 others	50/100
5th	Axxam 2001, Milan (Italy), Acquired	Provider of services for research application across life sciences industries	-	Keensight Capital	49/100
6th	ONCOHOST 2017, Binyamina Giv at Ada (Israel), Series C	AI-based oncology therapy plan solution for professionals	$43M	ALIVE, OurCrowd & 5 others	49/100
7th	Amplia Therapeutics 2000, North Melbourne (Australia), Public	Developer of therapies for treating cancer and pulmonary fibrosis	-	-	47/100
8th	Transnetyx 2000, Memphis (United States), Acquired	Developer of automated-genotyping services for murine cell lines	-	Abacus Finance Group, ventureCapital.org & 2 others	47/100
9th	Macrogen 1997, Seoul (South Korea), Public	Provider of a platform for next-generation sequencing	-	Atinum Investment, Aju IB Investment & 1 others	47/100
10th	Genechem 2002, Shanghai (China), Series C	Products and services in molecular biology	$56.4M	Free Trade Zone Fund, Humanwell Healthcare ... & 2 others	46/100
32nd	Genewiz 1999, South Plainfield (United States), Acquired	Provider of a wide range of genomic services for the life sciences industry	-	Orbimed, Ampersand Capital & 6 others	42/100